Enhanced Vascular Plasminogen Activator (t-PA) Release by Epinephrine in Aged Rats

Summary

Adrenergic stimulation induces an acute fibrinolytic response in the vascular wall and can play an important role in limiting thrombus growth. The incidence of thrombotic disease increases with age. As many adrenergic functions are affected by aging, the vascular response to adrenergic stimulation was studied in young (3 ± 1 months) and aged (18 ± 3 months) rats, using an experimental model of vascular perfusion. Five min epinephrine (EPI) infusion (0.15-25 μM) induced a dose-dependent increase in tissue-type plasminogen activator (t-PA) release and in perfusion pressure, in both young and aged rats. In the latter, however, the basal activity of t-PA was significantly higher than in young animals (0.22 ± 0.02 vs 0.13 ± 0.01 U/ml; means ± SE; p <0.01, n = 40) and EPI infusion induced a significantly higher increase in t-PA activity (0.78 ± 0.06 vs 0.47 ± 0.08 U/ml, p <0.01, for 6.25 μM EPI). The response was characterized by a delayed onset. In contrast, the increase in the perfusion pressure by EPI was significantly lower in aged that in young rats, its basal levels being normal.

To evaluate whether the increased vascular response of t-PA was peculiar for adrenergic stimulation, we infused platelet activating factor (PAF), an inducer of t-PA release, not related to catecholamines. PAF, during five-minute infusion induced a rapid and dose-dependent (100-1250 pM) increase in t-PA release, to the same extent in both young and aged rats.

In conclusion, basal t-PA secretion was increased in aged rats probably as a response of vascular endothelium to chronic stimulation. Moreover, the vascular fibrinolytic response to acute EPI stimulation was greater in aging. This response was specific for adrenoceptor stimulation and could represent an adaptative mechanism of adrenergic receptors, counteracting an increased thrombotic tendency.

• References

• 1 Maggioni AP, Maseri A, Fresco C, Franzosi MG, Mauri F, Santoro E, Tognoni G. GISSI-2, Age-related increase in mortality among patients with first myocardial infarction treated with thrombolysis. N Engl J Med 1993; 329: 1442-1448
• 2 Maseri A, Biasucci LM, Andreotti F. Age dependence of ischaemic heart syndromes and the contribution of haemostatic deviations. Fibrinolysis 1992; 6 suppl (Suppl. 03) 3-4
• 3 Collen D. On the regulation and control of fibrinolysis. Thromb Haemost 1980; 43: 77-89
• 4 Erickson LA, Schleef RR, Ny T, Loskutoff DJ. The fibrinolytic system of the vascular wall. Clin Haematol 1985; 14: 513-530
• 5 Iacoviello L, De CurtisA, Amore C, D'Adamo MC, Buczko W, de GaetanoG, Donati MB. Effect of aspirin on the fibrinolytic response in perfused rat hindquarters. Eur J Pharmacol 1992; 229: 39-44
• 6 D'Adamo MC, De Curtis A, Buczko W, Iacoviello L, Donati MB. The role of α-adrenergic receptors in the acute release of tissue-type plasminogen activator (t-PA) in a model of vascular perfusion in rats. Thromb Haemost 1993; 69 suppl (Suppl. 06) 544
• 7 Feldman RD, Limbird LE, Nadeau J, Robertson D, Wood AJ J. Alterations in leucocyte β-receptor affinity with aging. A potential explanation for altered β-adrenergic sensitivity in the elderly N Engl J Med 1984; 310: 815-819
• 8 Pfeifer MD, Weinberg CR, Cook D, Best JD, Reenan A, Halter JB. Differential changes of autonomic nervous system function with age in man. Am J Med 1983; 75: 249-258
• 9 Elliot HJ, Summer DJ, McLean K, Reid JL. Effect of age on the responsiveness of vascular a-adrenoceptors in man. J Cardiovasc Pharmacol 1982; 48: 388-392
• 10 Fleisch JG. Age-related decrease in beta-adrenoceptor activity of the cardiovascular system. Trends Pharmacol Sci 1981; 2: 337-339
• 11 Morrow LA, Morganroth GS, Hill TJ, Sanfield JA, Rosen SG, Grekin RJ, Halter JB. Atrial natriuretic factor in the elderly: diminished response to epinephrine. Am J Physiol 1989; 257: E866-E870
• 12 Stegnar M, Keber D, Pentek M, Vene N, Kluft C. Age and sex differences in resting and postocclusion values of tissue plasminogen activator in a healthy population. Fibrinolysis 1988; 2 supp (Suppl. 02) 121-122
• 13 Emeis JJ, Brouwer A, Barelds RJ, Horan MA, Durham SK, Kooistra T. On the fibrinolytic system in aged rats and its reactivity to endotoxin and cytokines. Thromb Haemost 1992; 67: 697-701
• 14 Buczko W, Iacoviello L, De Curtis A, Amore C, Donati MB. Aging and tissue plasminogen activator release. Thromb Haemost 1991; 66: 745
• 15 Iacoviello L, De Curtis A, D'Adamo MC, Donati MB. Different response of vascular fibrinolysis to adrenergic stimulation in young and aged rats. Fibrinolysis 1992; 6 supp (Suppl. 03) 36-38
• 16 Emeis JJ, Kluft C. PAF-Acether-induced release of tissue-type plasminogen activator from vessel walls. Blood 1985; 66: 86-91
• 17 Giles AR. Guidelines for the use of animals in biomedical research. Thromb Haemost 1987; 58: 1078-1084
• 18 Emeis JJ. Perfused rat hindlegs. A model to study plasminogen activator release Thromb Res 1983; 30: 195-203
• 19 Tranquille N, Emeis JJ. Release of tissue-type plasminogen activator is induced in rats by leukotrienes C4 and D4 but not by prostaglandins E1, E2, and 12. Br J Pharmacol 1988; 93: 156-164
• 20 De Curtis A, Iacoviello L, D'Adamo MC, Donati MB. Changes of the hemostatic balance in a model of aging in rats. Thromb Res 1993; 70: S143
• 21 Reyers I, Roncaglioni MC, de Gaetano G, Donati MB. Arterial thrombosis induced by the aortic loop technique. In: Standardization of animal models of thrombosis. Breddin K, Zimmermann R. eds Stuttgart-New York: Schattauer; 1983. pp 185-194
• 22 Gaussem P, Levy C, Vemy M, Angles-Cano E. Endothelial cell markers (vWF, t-PA and PAI-1) in the elderly. Thromb Haemost 1994; 72: 164-165
• 23 Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-1168
• 24 Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 940-943
• 25 Prowse CV, Cash JD. Physiologic and pharmacologic enhancement of fibrinolysis. Sem Thromb Hemost 1984; 10: 51-59
• 26 Iacoviello L, De CurtisA, Amore C, Buczko W, Donati MB. Effect of aspirin on plasminogen activator release in perfused rat hindlegs. Fibrinolysis 1992; 6: 63-68
• 27 Zhu GJ, Abbadini M, Donati MB, Mussoni L. Tissue-type plasminogen activator release in response to epinephrine in perfused rat hindlegs. Am J Physiol 1989; 256: H404-H410
• 28 Chandler WL, Veith RC, Fellingham GV, Levy WC, Schwartz RS, Cerqueira MD, Kahn SE, Larson VG, Cain KC, Beard JC, Abrass IB, Stratton JR. Fibrinolytic response during exercise and epinephrine infusion in the same subjects. J Am Coll Cardiol 1992; 19: 1412-1420
• 29 Fitzgerald D, Doyle V, Kelly JG, O'Malley K. Cardiac sensitivity to isoprenaline, lymphocyte |3-adrenoceptors and age. Clin Sci 1984; 66: 697-699
• 30 Davis PB, Silski C. Ageing and the α₂-adrenergic system of the platelet. Clin Sci 1987; 73: 507-513
• 31 Hyland L, Docherty JR. An investigation of age-related changes in pre- and postjunctional α-adrenoceptors in human saphenous vein. Eur J Pharmacol 1985; 114: 361-364
• 32 Kell J, O'Malley K. Adrenoceptor function and ageing. Clin Sci 1984; 66: 509-515
• 33 Van BrummelenP, Buhler FR, Kiowski W, Amann FW. Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. Clin Sci 1981; 60: 571-577
• 34 Vestal RE, Wood AJ, Shand DG. Reduced β-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979; 26: 181-186
• 35 Hanahan DJ. Platelet activating factor: a biologically active phospho- glyceride. Annu Rev Biochem 1986; 55: 483-509
• 36 Vargaftig BB, Benveniste J. Platelet-activating factor today. Trends Pharmacol Sci 1983; 4: 341-343